A carregar...
The Next Frontier: Head and Neck Cancer Immunoprevention
Restoring T cell mediated anti-tumor immunity by targeting immune checkpoint inhibitors in head neck squamous cell carcinoma (HNSCC) results in immune modulation and durable remissions. However, the overall response rate to these immunotherapies in HNSCC is only ~20%. This raises the possibility tha...
Na minha lista:
| Publicado no: | Cancer Prev Res (Phila) |
|---|---|
| Main Authors: | , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
2017
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5741293/ https://ncbi.nlm.nih.gov/pubmed/29138137 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1940-6207.CAPR-17-0331 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|